Clinical and Molecular Aspects of C2orf71/PCARE in Retinal Diseases

被引:3
|
作者
Zufiaurre-Seijo, Maddalen [1 ]
Garcia-Arumi, Jose [1 ]
Duarri, Anna [1 ]
机构
[1] Vall dHebron Hosp Univ, Vall dHebron Inst Recerca VHIR, Ophthalmol Res Grp, Barcelona 08035, Spain
关键词
retina; retinitis pigmentosa; cone-rod dystrophy; C2orf71; gene; PCARE; photoreceptors; cilia; ciliopathies; outer segment; RPE; OUTER SEGMENT; IN-VITRO; VORETIGENE NEPARVOVEC; PIGMENT EPITHELIUM; PATIENT COHORT; PRIMARY CILIUM; MUTATIONS; GENE; ACTIN; DIAGNOSIS;
D O I
10.3390/ijms241310670
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mutations in the photoreceptor-specific C2orf71 gene (also known as photoreceptor cilium actin regulator protein PCARE) cause autosomal recessive retinitis pigmentosa type 54 and cone-rod dystrophy. No treatments are available for patients with C2orf71 retinal ciliopathies exhibiting a severe clinical phenotype. Our understanding of the disease process and the role of PCARE in the healthy retina significantly limits our capacity to transfer recent technical developments into viable therapy choices. This study summarizes the current understanding of C2orf71-related retinal diseases, including their clinical manifestations and an unclear genotype-phenotype correlation. It discusses molecular and functional studies on the photoreceptor-specific ciliary PCARE, focusing on the photoreceptor cell and its ciliary axoneme. It is proposed that PCARE is an actin-associated protein that interacts with WASF3 to regulate the actin-driven expansion of the ciliary membrane during the development of a new outer segment disk in photoreceptor cells. This review also introduces various cellular and animal models used to model these diseases and provides an overview of potential treatments.
引用
收藏
页数:22
相关论文
共 50 条
  • [21] CDHR1和 C2orf71基因新变异相关的视锥视杆细胞营养不良
    虎学君
    李贞
    牛伟
    杨尚英
    芮雪
    盛迅伦
    容维宁
    中华眼底病杂志, 2022, 38 (08) : 656 - 662
  • [22] Molecular and clinical aspects of peroxisomal diseases
    Shimozawa, N.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2006, 29 : 12 - 12
  • [23] Molecular and clinical aspects of peroxisomal diseases
    Shimozawa, N.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2007, 30 (02) : 193 - 197
  • [24] Human prion diseases -: Molecular and clinical aspects
    Glatzel, M
    Stoeck, K
    Seeger, H
    Lührs, T
    Aguzzi, A
    ARCHIVES OF NEUROLOGY, 2005, 62 (04) : 545 - 552
  • [25] Syndromic Inherited Retinal Diseases: Genetic, Clinical and Diagnostic Aspects
    Tatour, Yasmin
    Ben-Yosef, Tamar
    DIAGNOSTICS, 2020, 10 (10)
  • [26] Retinal Blinding Disorders and Gene Therapy - Molecular and Clinical Aspects
    Lorenz, Birgit
    Preising, Markus
    Stieger, Knut
    CURRENT GENE THERAPY, 2010, 10 (05) : 350 - 370
  • [27] The clinical implications of molecular monitoring and analyses of inherited retinal diseases
    Chacon-Camacho, Oscar F.
    Garcia-Montano, Leopoldo A.
    Zenteno, Juan C.
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2017, 17 (11) : 1009 - 1021
  • [28] Molecular and Clinical Aspects of Protein Aggregation Assays in Neurodegenerative Diseases
    Anna Villar-Piqué
    Matthias Schmitz
    Niccolò Candelise
    Salvador Ventura
    Franc Llorens
    Inga Zerr
    Molecular Neurobiology, 2018, 55 : 7588 - 7605
  • [29] Molecular and Clinical Aspects of Protein Aggregation Assays in Neurodegenerative Diseases
    Villar-Pique, Anna
    Schmitz, Matthias
    Candelise, Niccolo
    Ventura, Salvador
    Llorens, Franc
    Zerr, Inga
    MOLECULAR NEUROBIOLOGY, 2018, 55 (09) : 7588 - 7605
  • [30] Clinical and molecular revaluation yield a 52% of characterization in syndromic retinal diseases
    Perea-Romero, Irene
    Blanco-Kelly, Fiona
    Sanchez-Navarro, Iker
    Lorda-Sanchez, Isabel
    Tahsin-Swafiri, Saoud
    Avila-Fernandez, Almu-Dena
    Martin-Merida, Inmaculada
    Trujillo-Tiebas, Maria Jose
    Lopez-Rodriguez, Rosario
    Iancu, Ionut Florin
    Romero, Raquel
    Quinodoz, Mathieu
    Minguez, Pablo
    Corton, Marta
    Rivolta, Carlo
    Ayuso, Carmen
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2022, 30 (SUPPL 1) : 139 - 140